Skip to cookie consent Skip to main content

Innovation

Mass General Brigham Innovation is a collaborative team of business development and investment professionals working with medical inventors, thought-leaders, entrepreneurs, and industry to shape the future of medicine.

MGH Mucosal Research lab researchers look at petri dish

Committed to medical innovations

Mass General Brigham Innovation is the business development arm of Mass General Brigham, responsible for the worldwide commercial application of the discoveries made by Mass General Brigham’s 80,000 employees. Our team works with medical inventors, investors, entrepreneurs, and industry.

Mass General Brigham Innovation mission

Our mission is to take medical inventions and innovations discovered by Mass General Brigham researchers and provide the support and infrastructure to enable technology development, commercialization, and, ultimately, the creation of healthcare treatments and products that benefit patients everywhere.

Converting invention to innovation

Innovation is responsible for industry collaborations, venture investing, licensing, company creation, technology marketing, open innovation alliances, and workforce development.

Licensing partnerships

Mass General Brigham Innovation works with investors and companies to license medical technologies in diagnostics, medical devices, research tools, medical software, therapeutics, and vaccines.

World Medical Innovation Forum

The tenth annual World Medical Innovation Forum gathered global leaders across healthcare, biotech and investment to explore the latest advancements and emerging trends in medicine. This year’s Forum highlighted pivotal fields like oncology, rare disease, inflammation and immunology, alongside Medicine’s Hottest Topics from generative AI to emerging therapies in cancer, weight loss drugs, home health, and psychedelics.

Panelists speaking at World Medical Innovation Forum

Over 200 years

of pushing the boundaries of medicine and leading innovative science

Line drawing of vial

$450M

capital under management

Line drawing of dollar bills

$165M

in average annual licensing revenue

Learn more about Mass General Brigham Ventures

Single glass flask with double exposure scientist or researcher holding tube in chemistry blue laboratory with stock market information background